Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Patient Positioning × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Conditions

Disease 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 1279 Cisplatin 1203 Paclitaxel 1130 Radiotherapy 1108 Carboplatin 1071 Gemcitabine 1051 Docetaxel 961 Bevacizumab 893 Fluorouracil 771 Doxorubicin 682 Dexamethasone 644 Capecitabine 643 Rituximab 622 Oxaliplatin 601 Etoposide 583 Irinotecan 553 pembrolizumab 551 Filgrastim 541 Cytarabine 505 Leucovorin 504 Nivolumab 457 Vincristine 440 Prednisone 407 Cetuximab 401 Bortezomib 401 Erlotinib Hydrochloride 392 Trastuzumab 382 Methotrexate 366 Lenalidomide 361 Pemetrexed 357

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02865239 2018-08-08

EFIMED

Institut de Cancérologie de Lorraine

Phase NA Completed

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡